Patent Agent
Audrey has worked in a variety of intellectual property departments in both the United States and Europe. Most recently, she worked at a Belgium-based biopharma company specializing in neurological and autoimmune conditions. She handled IP strategy, patent drafting and prosecution, and freedom-to-operate analyses in support of early-stage products in gene therapy and antibody therapeutics. Audrey developed experience in patent strategy and prosecution through working at a 3D printing company and a university technology transfer office, both in Belgium, and with a general practice law firm in Boston, Massachusetts.
Audrey's scientific training as a doctorate student at Massachusetts Institute of Technology (MIT) focused on the molecular mechanisms underlying synaptic plasticity.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.